References
- Abdelhalim M.A.K., JarrarB.M. (2011 a). Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles. Lip. Health Dis., 10: 163.
- Abdelhalim M.A.K., JarrarB.M. (2011 b). The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity. Lip. Health Dis., 10: 147.
- Abdelhalim M.A.K., Jarrar B.M. (2012). Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration. J. Nanobiotechnol., 10: 5.
- Abdelhalim M.A.K., Moussa S.A.A. (2012). The dimensional hematological alterations induced in blood of rats in vivo by intraperitoneal administration of gold nanoparticles. J. Nanomed. Nano-technol., 3: 138.
- Abdelhalim M.A.K., Moussa S.A.A. (2013). The gold nanoparticle size and exposure duration effect on the liver and kidney function of rats: in vivo. Saudi J. Biol. Sci., 2: 177–181.
- Adayemi O.S., Whiteley C.G. (2014). Interaction of metal nanoparticles with recombinant arginine kinase from Trypanosoma brucei: Thermodynamic and spectrofluorimetric evaluation. Bioch. Biophys. Acta, 1840: 701–706.
- Ahmadi F. (2012). Impact of different levels of silver nanoparticles (Ag-NPs) on performance, oxidative enzymes and blood parameters in broiler chicks. Pak. Vet. J., 32: 325–328.
- Alkilany A.M., Murphy C.J. (2010). Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res., 12: 2313–2333.
- Barath Mani Kanth S., Kalishwaralal K., Sriram M., Pandian S.R.K., Youn H., Eom S., Gurunathan S. (2010). Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J. Nanobiotechnol., 8: 16.
- Bartosz G. (2004). Second face of oxygen (in Polish). Polish Scientific Publishers PWN, Warsaw, pp. 376–378.
- Berce C., Lucan C., Petrushev B., Boca S., Miclean M., Sarpataki O., Astilean S., Buzoianu A., Tomuleasa C., Bojan A. (2016). In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice. Int. J. Nanomed., 1: 4261–4273.
- Bilska A., Kryczyk A., Włodek L. (2007). The different aspects of the biological role of glutathione (in Polish). Post. Hig. Med. Dosw., 61: 428–453.
- Chen L.Q., Fang L., Ling J., Ding C.Z., Kang B., Huang C.Z. (2015). Nanotoxicity of silver nanoparticles to red blood cells: size dependent adsorption, uptake, and hemolytic activity. Chem. Res. Toxicol., 28: 501–509.
- Chen Y.S., Hung Y.C., Liau I., Huang G.S. (2009). Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res. Lett., 4: 858–864.
- Cho W.S., Cho M., Jeong J., Choi M., Cho H.Y., Han B.S., Kim S.H., Kim H.O., Lim Y.T., Chung B.H., Jeong J. (2009). Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Tox. Appl. Pharmacol., 236: 16–24.
- Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. (2005). Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 1: 325–327.
- Dobrovolskaia M.A., Patri A.K., Zheng J., Flogston J.D., Ayub N., Aggarwal P. (2009). Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine, 5: 106–117.
- Dykman L., Khlebtsov N. (2017). Immunological properties of gold nanoparticles. Chem. Sci., 8: 1719–1735.
- Gay C.A., Gębicki J.M. (2002). Perchloric acid enhances sensitivity and reproducibility of the ferric-xylenol orange peroxide assay. Anal. Biochem., 304: 42–46.
- Gianini E.G., Testa R., Savarino V. (2005). Liver enzyme alterations: a guide for clinicians. CMAJ, 271: 367–379.
- Jia H.Y., Liu Y., Zhang X.J., Han L., Du L.B., Tian Q., Xu Y.C. (2009). Potential oxidative stress of gold nanoparticles by induced-NO releasing in serum. J. Am. Chem. Soc., 131: 40–41.
- Jo M.R., Bae S.H., Go M.R., Kim H.J., Hwang Z.G., Choi S.J. (2015). Toxicity and biokinetics of colloidal gold nanoparticles. Nanomaterials, 5: 835–850.
- Jovanović B., Palić D. (2012). Immunotoxicology of non-functionalized engineered nanoparticles in aquatic organisms with special emphasis on fish – review of current knowledge, gap identification, and call for further research. Aquatic Toxicol., 118/119: 141–151.
- Kasarala G., Tillmann M.D. (2016). Standard liver tests. Clin. Liver Dis., 8: 13–18.
- Lasagna-Reeves C., Gonzalez-Romero D., Barria M.A., Olmedo I., Clos A., Ra-manujam V.M.S.A., Urayama A., Vergara L., Kogan M.J., Soto C. (2010). Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Bioch. Bioph. Res. Comm., 393: 649–655.
- Leroy P., Sapin-Minet A., Pitarch A., Boudier A., Tournebize J. (2011). Interaction between gold nanoparticles and macrophages: activation or inhibition? Nitric Oxide, 25: 54–56.
- Li X., Robinson S.M., Gupta A., Saha K., Jiang Z., Moyano D.F., Sahar A., Ri-ley M.A., Rotello V.M. (2014). Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano, 8: 10682–10686.
- Lis K. (2012). Erythrocyte sedimentation rate in the past and present day (in Polish). J. Lab. Diag., 48: 213–218.
- Maj S. (2000). Drug-induced blood dyscrasias (in Polish). Post. Nauk Med., 4: 17–28.
- Małaczewska J. (2015). Effect of oral administration of commercial gold nanocolloid on peripheral blood leukocytes in mice. Pol. J. Vet. Sci., 18: 273–282.
- Nel A., Xia T., Mädler L., Li N. (2006). Toxic potential of materials at the nanolevel. Science, 311: 622–627.
- Nelson B.C., Petersen E.J., Marquis B.J., Atha D.H., Elliott J.T., Cleveland D., Watson S.S., Tseng I.H., Dillon A., Theodore M., Jackman J. (2013). NIST gold nanoparticle reference materials do not induce oxidative DNA damage. Nanotoxicology, 7: 21–29.
- Ognik K., Cholewińska E., Czech A., Kozłowski K., Wlazło Ł., Nowakowicz-Dębek B., Szlązak R., Tutaj K. (2016). Effect of silver nanoparticles on the immune, redox, and lipid status of chicken blood. Czech J. Anim. Sci., 61: 450–461.
- Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., Brandau W., Si-mon U., Jahnen-Dechen W. (2009). Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small, 5: 2067–2076.
- Pineda L., Sawosz E., Hotowy A., Elnif J., Sawosz F., Ali A., Chwalibog A. (2012). Effect of nanoparticles of silver and gold on metabolic rate and development of broiler and layer embryos. Comp. Bioch. Physiol., Part A, 161: 315–319.
- Salih M., Smith D.M., Price J.F., Dawson L.E. (1987). Modified extraction 2-thiobarbituric acid method for measuring lipid oxidation in poultry. Poultry Sci., 66: 1483–1488.
- Saptarshi S.R., Duschl A., Lopata A.L. (2013). Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticles. J. Nanobiotechnol., 11: 26.
- Sarkar A., Ghosh M., Sil P.C. (2014). Nanotoxicity: Oxidative stress mediated toxicity of metal and metal oxide nanoparticles. J. Nanosci. Nanotechnol., 14: 730–743.
- Sawosz E., Grodzik M., Lisowski P., Zwierzchowski L., Niemiec T., Szmidt M., Chwalibog A. (2010). Influence of hydrocolloids of Ag, Au, and Ag/Cu alloy nanoparticles on the inflammatory state at transcriptional level. Bull. Vet. Inst. Pulawy, 54: 81–85.
- Schrand A.M., Braydich-Stolle L.K., Schlager J.J., Dai L., Hussain S.M. (2008). Can silver nanoparticles be useful as potential biological labels? Nanotechnology, 19: 1–13.
- Sembratowicz I., Ognik K. (2018). Immunotropic activity of gold nanocolloid in chickens. J. Trace El. Med. Biol., 47: 98–103.
- Sembratowicz I., Ognik K., Stępniowska A. (2016). An evaluation of in vitro intestinal absorption of iron, calcium and potassium in chickens receiving gold nanoparticles. Brit. Poultry Sci., 57: 559–565.
- Sengupta J., Datta P., Patra H.K., Dasgupta A.K., Gomes A. (2013). In vivo interaction of gold nanoparticles after acute and chronic exposure in experimental animal models. J. Nanosci. Nanotechnol., 13: 1660–1670.
- Shamaila S., Zafer N., Riaz S., Shariff R., Nazir J., Naseem S. (2014). Gold nanoparticles: an efficient antimicrobial agent against enteric human bacterial pathogens. Nanomaterials, 6: 71.
- Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. (2005). Bio-compatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir, 21: 10644–10654.
- Siddiqi K.S., Husen A. (2017). Recent advances in plant-mediated engineered gold nanoparticles and their application in biological system. J. Trace El. Med. Biol., 40: 10–23.
- Smulikowska S., Rutkowski A. (2005). Nutrient requirements of poultry, 4th rev. ed. (in Polish). The Kielanowski Institue of Anim. Physiol. Nutr. PAS.
- Sumbayev V.V., Yasinska I.M., Garcia C.P., Gilliland D., Lall G.S., Gibbs B.F., Bonsall D.R., Varani L., Rossi F., Calzolai L. (2013). Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small, 9: 472–477.
- Surekha K. (2017). Gold nanoparticles: their application as antimicrobial agents and vehicles of gene delivery. Adv. Biotechnol. Microbiol., 4: 555658.
- Unfried K., Albrecht C., Klotz L.O., Mikecz A., Grether-Beck S., Schins R.P.F. (2007). Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology, 1: 52–71.
- Valchev I., Kanakov D., Hristov T., Lazarov L., Binev R., Grozeva N., Niko-lov Y. (2014). Effects of experimental aflatoxicosis on renal function in broiler chickens. Bulg. J. Vet. Med., 17: 314–324.
- Wiwanitkit V., Sereemaspun A., Rojanathanes R. (2010). Identification of gold nanoparticle in lymphocytes: a confirmation of direct intracellular penetration effect. Turk. J. Hematol., 26: 28–30.
- Xu Y., Tang H., Liu J.H., Wang H., Liu Y. (2013). Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo. Toxicol. Lett., 219: 42–48.
- Yah C.S. (2013). The toxicity of gold nanoparticles in relation to their physicochemical properties. Biomed. Res., 24: 400–413.
- Yang H., Du L., Tian X., Fan Z., Sun C., Liu Y. (2014). Effects of nanoparticle size and gestational age on maternal biodistribution and toxicity of gold nanoparticles in pregnant mice. Toxicol. Lett., 230: 10–18.
- Zhang X.D., Wu H.Y., Wu D., Wang X.Y., Chang J.H., Zhai Z.B., Meng A.M., Liu P.X., Zhang L.A., Fan F.Y. (2010). Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J. Nanomed., 5: 771–781.
- Zhang X.D., Wu D., Shen X., Liu P.X., Yang N., Zhao B., Zhang H., Sun Y.M., Zhang L., Fan F.Y. (2011). Size-dependent in vivo toxicity of PEG coated gold nanoparticles. Int. J. Nanomed., 6: 2071–2081.
- Ziaee Ghahnavieh M., Ajdary M., Ziaee Ghahnavieh M., Naghsh N. (2014). Effects of intraperitoneal injection of gold nanoparticles in male mice. Nanomed. J., 1: 121–127.
- Zielińska M., Sawosz E., Grodzik M., Balcerak M., Wierzbicki M., Skomiał J., Sawosz F., Chwalibog A. (2011 a). Effect of taurine and gold nanoparticles on the morphological and molecular characteristics of muscle development during chicken embryogenesis. Arch. Anim. Nutr., 66: 1–13.
- Zielińska M., Sawosz E., Grodzik M., Wierzbicki M., Gromadka M., Hotowy A., Sawosz F., Lozicki A., Chwalibog A. (2011 b). Effect of heparan sulfate and gold nanoparticles on muscle development during embryogenesis. Int. J. Nanomed., 6: 3163–3172.
- Zolnik B.S., González-Fernández Á., Sadrieh N., Dobrovolskaia M.A. (2010). Nanoparticles and the immune system. Endocrinology, 151: 458–465.